Growth Metrics

MeiraGTx Holdings (MGTX) Net Cash Flow (2017 - 2025)

MeiraGTx Holdings posted quarterly Net Cash Flow of $50.8 million for Q4 2025, up 351.01% year-on-year from $11.3 million in Q4 2024, and up 492.32% on a QoQ basis from -$13.0 million in Q3 2025.

MeiraGTx Holdings (MGTX) has 9 years of Net Cash Flow data on file, last reported at $50.8 million in Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow rose 351.01% year-over-year to $50.8 million; the trailing twelve-month figure through Dec 2025 stood at -$38.2 million (down 44.38% YoY), and the FY2025 full-year result was -$38.2 million, down 44.38% from the prior year.
  • Net Cash Flow for Q4 2025 stood at $50.8 million, up from -$13.0 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $64.3 million in Q4 2023 and bottomed at -$47.2 million in Q1 2023.
  • The 5-year median for Net Cash Flow is -$16.1 million (2024), against an average of -$7.3 million.
  • The widest annual swing landed in 2023, when Net Cash Flow surged 86848.65%; it then sank 245.09% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at -$5.2 million in 2021, then soared by 101.41% to $74000.0 in 2022, then soared by 86848.65% to $64.3 million in 2023, then slumped by 131.47% to -$20.2 million in 2024, then jumped by 351.01% to $50.8 million in 2025.
  • The last three Net Cash Flow figures came in at $50.8 million (Q4 2025), -$13.0 million (Q3 2025), and -$39.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 2.44 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 625.70 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -2.44 Mn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 457.40 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -152.20 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 60.68 Mn
10 MeiraGTx Holdings 856.58 Mn 790.65 Mn 74.89 Mn 50.83 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 50.83 Mn
Dec 31, 2025 50.83 Mn
Sep 30, 2025 -12.96 Mn
Sep 30, 2025 -12.96 Mn
Jun 30, 2025 -39.28 Mn
Jun 30, 2025 -39.28 Mn
Mar 31, 2025 -36.83 Mn
Mar 31, 2025 -36.83 Mn
Dec 31, 2024 -20.25 Mn
Dec 31, 2024 -20.25 Mn
Sep 30, 2024 23.62 Mn
Sep 30, 2024 23.62 Mn
Jun 30, 2024 -19.18 Mn
Jun 30, 2024 -19.18 Mn
Mar 31, 2024 -10.67 Mn
Mar 31, 2024 -10.67 Mn
Dec 31, 2023 64.34 Mn
Dec 31, 2023 64.34 Mn
Sep 30, 2023 -28.38 Mn
Sep 30, 2023 -28.38 Mn
Jun 30, 2023 23.96 Mn
Jun 30, 2023 23.96 Mn
Mar 31, 2023 -47.23 Mn
Mar 31, 2023 -47.23 Mn
Dec 31, 2022 74,000.00
Dec 31, 2022 74,000.00
Sep 30, 2022 42.21 Mn
Sep 30, 2022 42.21 Mn
Jun 30, 2022 -41.81 Mn
Jun 30, 2022 -41.81 Mn
Mar 31, 2022 -23.34 Mn
Mar 31, 2022 -23.34 Mn
Dec 31, 2021 -5.25 Mn
Dec 31, 2021 -5.25 Mn
Sep 30, 2021 -29.03 Mn
Sep 30, 2021 -29.03 Mn
Jun 30, 2021 -26.61 Mn
Jun 30, 2021 -26.61 Mn
Mar 31, 2021 -9.65 Mn
Mar 31, 2021 -9.65 Mn
Dec 31, 2020 29.64 Mn
Dec 31, 2020 29.64 Mn
Sep 30, 2020 -15.84 Mn
Sep 30, 2020 -15.84 Mn
Jun 30, 2020 -15.80 Mn
Jun 30, 2020 -15.80 Mn
Mar 31, 2020 -16.26 Mn
Mar 31, 2020 -16.26 Mn
Dec 31, 2019 -26.64 Mn
Dec 31, 2019 -26.64 Mn
Sep 30, 2019 49.78 Mn
Sep 30, 2019 49.78 Mn
Jun 30, 2019 -22.84 Mn
Jun 30, 2019 -22.84 Mn
Mar 31, 2019 158.62 Mn
Mar 31, 2019 158.62 Mn
Dec 31, 2018 -20.36 Mn
Dec 31, 2018 -20.36 Mn
Sep 30, 2018 -13.47 Mn
Sep 30, 2018 -13.47 Mn
Jun 30, 2018 69.93 Mn
Jun 30, 2018 69.93 Mn
Mar 31, 2018 23.80 Mn
Mar 31, 2018 23.80 Mn
Dec 31, 2017 3.27 Mn
Dec 31, 2017 3.27 Mn
Sep 30, 2017 139,562.00
Sep 30, 2017 139,562.00